NVAX - Novavax, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue34,28831,17615,35336,250
Cost of Revenue173,797168,435237,939162,644
Gross Profit-139,509-137,259-222,586-126,394
Operating Expenses
Research Development----
Selling General and Administrative34,40934,45146,52730,842
Non Recurring----
Others----
Total Operating Expenses208,206202,886284,466193,486
Operating Income or Loss-173,918-171,710-269,113-157,236
Income from Continuing Operations
Total Other Income/Expenses Net-10,830-12,059-10,853299
Earnings Before Interest and Taxes-173,918-171,710-269,113-157,236
Interest Expense-13,612-14,072-12,965-241
Income Before Tax-184,748-183,769-279,966-156,937
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-184,748-183,769-279,966-156,937
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-184,748-183,769-279,966-156,937
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-184,748-183,769-279,966-156,937